Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: A meta-analysis

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Pabalan, Noel ^a,b,c   Trevisan, Camila Martins ^d   Peluso, Carla ^d   Jarjanazi, Hamdi ^e   Christofolini, Denise Maria ^d   Barbosa, Caio Parente ^d   Bianco, Bianca ^d  

^a ANGELES UNIVERSITY FOUNDATION   (Philippines)

^b Graduate School Cebu Doctors University   (Philippines)

^c SAINT LOUIS UNIVERSITY   (Philippines)

^d FACULDADE DE MEDICINA DO ABC   (Brazil)

^e ONTARIO MINISTRY OF THE ENVIRONMENT   (Canada)

Author keywords

Follicle stimulating hormone receptor; FSHR; Meta analysis; Ovarian response; Polymorphisms

Indexed keywords

ASPARAGINE; FOLLITROPIN RECEPTOR; SERINE;

ALLELE; ARTICLE; CAUCASIAN; FSHR GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; TREATMENT RESPONSE; CASE CONTROL STUDY; FEMALE; GENETICS; INFERTILITY, FEMALE; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FSH; TREATMENT OUTCOME;

EID: 84964697026     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/s13048-014-0122-2     Document Type: Article

References (59)

1. Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, Taieb S, Wainer R, Benahmed M, de Mazancourt P, Selva J, Vialard F: Genetic polymorphisms influence the ovarian response to rfsh stimulation in patients undergoing in vitro fertilization programs with icsi. PLoS One 2012, 7:e38700.
2. Mohiyiddeen L, Nardo LG: Single-nucleotide polymorphisms in the fsh receptor gene and ovarian performance: Future role in ivf. Human Fertil (Cambridge England) 2010, 13:72-78.
3. Sheikhha MH, Eftekhar M, Kalantar SM: Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Human Reprod Sci 2011, 4:86-90.
4. Huang X, Li L, Hong L, Zhou W, Shi H, Zhang H, Zhang Z, Sun X, Du J: The ser680asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation. Clin Endocrinol (Oxf) 2014, doi: 10.1111/cen.12573. [Epub ahead of print]
5. Lledo B, Guerrero J, Turienzo A, Ortiz JA, Morales R, Ten J, Llacer J, Bernabeu R: Effect of follicle-stimulating hormone receptor n680s polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics 2013, 23:262-268.
6. Kligman I, Rosenwaks Z: Differentiating clinical profiles: Predicting good responders, poor responders, and hyperresponders. Fertil Steril 2001, 76:1185-1190.
7. Haller K, Salumets A, Uibo R: Anti-fsh antibodies associate with poor outcome of ovarian stimulation in ivf. Reprod Biomed Online 2008, 16:350-355.
8. Freour T, Masson D, Mirallie S, Jean M, Bach K, Dejoie T, Barriere P: Active smoking compromises ivf outcome and affects ovarian reserve. Reprod Biomed Online 2008, 16:96-102.
9. Coccia ME, Rizzello F: Ovarian reserve. Ann N Y Acad Sci 2008, 1127:27-30.
10. Altmae S, Haller K, Peters M, Hovatta O, Stavreus-Evers A, Karro H, Metspalu A, Salumets A: Allelic estrogen receptor 1 (esr1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod 2007, 13:521-526.
11. Altmae S, Hovatta O, Stavreus-Evers A, Salumets A: Genetic predictors of controlled ovarian hyperstimulation: Where do we stand today? Hum Reprod Update 2011, 17:813-828.
12. Moron FJ, Ruiz A: Pharmacogenetics of controlled ovarian hyperstimulation: Time to corroborate the clinical utility of fsh receptor genetic markers. Pharmacogenomics 2010, 11:1613-1618.
13. de Castro F, Moron FJ, Montoro L, Galan JJ, Hernandez DP, Padilla ES, Ramirez-Lorca R, Real LM, Ruiz A: Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004, 14:285-293.
14. Gharib SD, Wierman ME, Shupnik MA, Chin WW: Molecular biology of the pituitary gonadotropins. Endocr Rev 1990, 11:177-199.
15. Simoni M, Gromoll J, Nieschlag E: The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997, 18:739-773.
16. Segaloff DL, Ascoli M: The lutropin/choriogonadotropin receptor ? 4 years later. Endocr Rev 1993, 14:324-347.
17. Gromoll J, Simoni M: Follicle-stimulating-hormone receptor and twinning. Lancet 2001, 357:230. author reply 231-232.
18. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, de la Chapelle A: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995, 82:959-968.
19. Simoni M, Tempfer CB, Destenaves B, Fauser BC: Functional genetic polymorphisms and female reproductive disorders: Part i: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008, 14:459-484.
20. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M: Ovarian response to follicle-stimulating hormone (fsh) stimulation depends on the fsh receptor genotype. J Clin Endocrinol Metab 2000, 85:3365-3369.
21. Simoni M, Nieschlag E, Gromoll J: Isoforms and single nucleotide polymorphisms of the fsh receptor gene: Implications for human reproduction. Hum Reprod Update 2002, 8:413-421.
22. Yao Y, Ma CH, Tang HL, Hu YF: Influence of follicle-stimulating hormone receptor (fshr) ser680asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis. Mol Genet Metab 2011, 103:388-393.
23. Laan M, Grigorova M, Huhtaniemi IT: Pharmacogenetics of follicle-stimulating hormone action. Current Opin Endocrinol Diabetes Obesity 2012, 19:220-227.
24. Kene PS, Nalavadi VC, Dighe RR, Iyer KS, Mahale SD: Identification of the structural and functional determinants of the extracellular domain of the human follicle stimulating hormone receptor. J Endocrinol 2004, 182:501-508.
25. Clark MF, Baudouin SV: A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 2006, 32:1706-1712.
26. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
27. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
28. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ Clin Res 2003, 327:557-560.
30. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
31. Ioannidis JP, Trikalinos TA: The appropriateness of asymmetry tests for publication bias in meta-analyses: A large survey. Cmaj 2007, 176:1091-1096.
32. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
33. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: The prisma statement. PLoS Med 2009, 6:e1000097.
34. Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, Makrigiannakis A: Fsh receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering ivf/icsi-et programs. J Assist Reprod Genet 2006, 23:177-184.
35. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD: Follicle-stimulating hormone receptor polymorphism (thr307ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in indian women. Fertil Steril 2009, 91:432-439.
36. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G, Delbaere A: Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor ser680asn polymorphism. J Clin Endocrinol Metab 2004, 89:6310-6315.
37. de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez-Casas Padilla E, Real LM, Ruiz A: Role of follicle-stimulating hormone receptor ser680asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril 2003, 80:571-576.
38. Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, de Jong FH, Looman CW, Broekmans FJ: Fsh receptor genotype is associated with pregnancy but not with ovarian response in ivf. Reprod Biomed Online 2006, 13:687-695.
39. Livshyts G, Podlesnaja S, Kravchenko S, Sudoma I, Livshits L: A distribution of two snps in exon 10 of the fshr gene among the women with a diminished ovarian reserve in ukraine. J Assist Reprod Genet 2009, 26:29-34.
40. Mohiyiddeen L, Newman WG, Cerra C, McBurney H, Mulugeta B, Roberts SA, Nardo LG: A common asn680ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertil Steril 2013, 99:149-155.
41. Yan Y, Gong Z, Zhang L, Li Y, Li X, Zhu L, Sun L: Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in chinese women: A prospective clinical study. PLoS One 2013, 8:e78138.
42. Binder H, Strick R, Zaherdoust O, Dittrich R, Hamori M, Beckmann MW, Oppelt PG: Assessment of fshr variants and antimullerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertil Steril 2012, 97:1169-1175. e1161.
43. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, Lee GH, Lee WD, Kim SH, Kim JG, Moon SY: Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for ivf-et. J Hum Genet 2006, 51:665-670.
44. La Marca A, Sighinolfi G, Argento C, Grisendi V, Casarini L, Volpe A, Simoni M: Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil Steril 2013, 99:970-978. e971.
45. Loutradis D, Theofanakis C, Anagnostou E, Mavrogianni D, Partsinevelos GA: Genetic profile of snp(s) and ovulation induction. Curr Pharm Biotechnol 2012, 13:417-425.
46. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, Seliger E, Ropke F, Gromoll J, Nieschlag E, Simoni M: Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (fsh) receptor gene for the ovarian response to fsh: A pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005, 15:451-456.
47. Keay SD, Liversedge NH, Mathur RS, Jenkins JM: Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997, 104:521-527.
48. Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F, Volpe A: Perifollicular doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 2000, 74:809-812.
49. Luborsky JL, Thiruppathi P, Rivnay B, Roussev R, Coulam C, Radwanska E: Evidence for different aetiologies of low estradiol response to fsh: Age-related accelerated luteinization of follicles or presence of ovarian autoantibodies. Human Reprod (Oxford England) 2002, 17:2641-2649.
50. Balasch J, Creus M, Fabregues F, Carmona F, Casamitjana R, Ascaso C, Vanrell JA: Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol 1996, 175:1226-1230.
51. Barnhart K, Osheroff J: Follicle stimulating hormone as a predictor of fertility. Current Opin Obstetrics Gynecol 1998, 10:227-232.
52. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL: High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996, 65:961-965.
53. Oktay K, Briggs D, Gosden RG: Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 1997, 82:3748-3751.
54. Cai J, Lou HY, Dong MY, Lu XE, Zhu YM, Gao HJ, Huang HF: Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells. Fertil Steril 2007, 87:1350-1356.
55. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J: A method for meta-analysis of molecular association studies. Stat Med 2005, 24:1291-1306.
56. Loutradis D, Vlismas A, Drakakis P, Antsaklis A: Pharmacogenetics in ovarian stimulation? current concepts. Ann N Y Acad Sci 2008, 1127:10-19.
57. Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, Uitterlinden AG, De Jong FH, Pols HA, Simoni M, Visser JA: Anti-mullerian hormone and anti-mullerian hormone type ii receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Human Reprod (Oxford England) 2007, 22:1547-1554.
58. Moron FJ, de Castro F, Royo JL, Montoro L, Mira E, Saez ME, Real LM, Gonzalez A, Manes S, Ruiz A: Bone morphogenetic protein 15 (bmp15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (ohss). Pharmacogenet Genomics 2006, 16:485-495.
59. van Disseldorp J, Franke L, Eijkemans R, Broekmans F, Macklon N, Wijmenga C, Fauser B: Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous fsh for ivf. Reprod Biomed Online 2011, 22:382-388.